Biologics and Biosimilars: Background and Key Issues
Description:
This report discusses biologic and biosimilar medicines and their production and approval by the FDA. Recent legislation regarding FDA approval regulations and federal research and drug development are also discussed.
Date:
October 27, 2017
Creator:
Johnson, Judith A.
Item Type:
Refine your search to only
Report